08:34 AM EDT, 07/16/2026 (MT Newswires) -- UBS on Thursday started its coverage of healthcare company Dallah Healthcare (SASE:4004) with a neutral rating and a price target of 116.00 Saudi riyals. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.